merck glp-1 agonist Current Insights, Advantages and Challenges of Small Molecule Glucagon-like Peptide 1 Receptor Agonists: A Scoping Review New GLP-1 Guidelines for Type
Description
This makes it the first triple-agonist peptide to reach advanced clinical development
[(accessed on 21 March 2025)]
Benefit and formulary strategy
doi: 10.4093/dmj.2012.36.4.262
Aroda VR, Rosenstock J, Terauchi Y, et al
Clinical studies have shown that these medications can be powerful tools in the management of obesity, type 2 diabetes, and other metabolic conditions
